miR-30e-5p通过Cyb561/ROS信号通路调节白血病干细胞的自我更新
Haematologica
|August 16, 2023
概括
微RNA miR-30e-5p,在急性髓性白血病 (AML) 中经常降低,通过准Cyb561.1,抑制白血病干细胞 (LSC) 自再生. 这一发现为AML治疗提供了新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 白血病干细胞 (LSCs) 驱动急性髓性白血病 (AML) 的启动,维持和复发.
- 了解LSC自我更新机制对于开发有效的AML疗法至关重要.
- 针对LSC提供了一个有希望的策略,以预防疾病复发和改善患者的治疗结果.
研究的目的:
- 研究miR-30e-5p在调节AML中的LSC自我更新中的作用.
- 为了确定参与LSC调节的miR-30e-5p的分子点.
- 探索在AML中调节miR-30e-5p/Cyb561轴的治疗潜力.
主要方法:
- 定量实时PCR测量miR-30e-5p在AML和健康样本中的表达.
- 在体内白血病生成试验中,强制表达miR-30e-5p.
- 西方涂抹和光酶记者分析证实Cyb561是直接的miR-30e-5p目标.
- 在人类AML细胞中进行ROS试验和细胞增殖试验,对miR-30e-5p或Cyb561.1进行基因或药理操作.
主要成果:
- 与健康对照组相比,miR-30e-5p表达在AML患者样本中显著下调.
- 强制表达miR-30e-5p抑制白血病发生,损害LSC自我更新,并延长体内生存时间.
- Cyb561是miR-30e-5p的直接目标;它的缺乏限制了通过ROS信号的LCS自我更新.
- 过度表达miR-30e-5p或淘汰Cyb561抑制人类AML细胞生长.
结论:
- miR-30e-5p/Cyb561/ROS轴是AML中LSC自我更新的关键调节器.
- miR-30e-5p通过准Cyb561和调节ROS信号来作为瘤抑制剂.
- Cyb561代表了针对LSC导向的AML治疗的潜在治疗标.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
10:21Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
10.0K
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
